It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Some features of ATS will be disabled while you continue to use an ad-blocker.
reply to post by Aliensun
When I was a youngster a long ago, I remember if somebody said they had a wart, an elder would say, "Can I buy it from you for a penny?" After explaining that the wart would go away once it was purchased, the one with the wart, usually, a child or youngster, agreed and would take the penny. My understand is that technique worked because the youngster believed it would work. "Power of suggestion" some would say.
The Devil's apple, or Solanum linnaeanum has an active ingredient which shows early promise as a cancer treatment. www.cosmosmagazine.com...
The sap from Euphorbia peplus is effective against human nonmelanoma skin cancers
British Journal of Dermatology
Early View (Articles online in advance of print)
1. J.R. Ramsay1,
2. A. Suhrbier2,3,
3. J.H. Aylward4,
4. S. Ogbourne2,
5. S.-J. Cozzi2,
6. M.G. Poulsen1,
7. K.C. Baumann1,
8. P. Welburn4,
9. G.L. Redlich4,
10. P.G. Parsons2,3
Article first published online: 27 JAN 2011
1 Mater Radiation Oncology Centre, Brisbane, Qld, Australia
2 Queensland Institute of Medical Research, Post Office Royal Brisbane Hospital, Brisbane, Qld 4029, Australia
3 Griffith Medical Research College, Griffith University, Brisbane, Qld, Australia
4 Peplin Biotech Ltd, Brisbane, Qld, Australia
Background The sap from Euphorbia peplus, commonly known as petty spurge in the U.K. or radium weed in Australia, has been used as a traditional treatment for a number of cancers.
Objective To determine the effectiveness of E. peplus sap in a phase I/II clinical study for the topical treatment of basal cell carcinomas (BCC), squamous cell carcinomas (SCC) and intraepidermal carcinomas (IEC).
Methods Thirty-six patients, who had refused, failed or were unsuitable for conventional treatment, were enrolled in a phase I/II clinical study. A total of 48 skin cancer lesions were treated topically with 100–300 μL of E. peplus sap once daily for 3 days.
Results The complete clinical response rates at 1 month were 82% (n = 28) for BCC, 94% (n = 16) for IEC and 75% (n = 4) for SCC. After a mean follow-up of 15 months these rates were 57%, 75% and 50%, respectively. For superficial lesions < 16 mm, the response rates after follow-up were 100% for IEC (n = 10) and 78% for BCC (n = 9).
Conclusions The clinical responses for these relatively unfavourable lesions (43% had failed previous treatments, 35% were situated in the . and neck region and 30% were > 2 cm in diameter), are comparable with existing nonsurgical treatments. An active ingredient of E. peplus sap has been identified as ingenol mebutate (PEP005). This clinical study affirms community experience with E. peplus sap, and supports further clinical development of PEP005 for the treatment of BCC, SCC and IEC.
Originally posted by davespanners
I'm so bored of this obsession with categorizing every single thing on earth as either causing or curing cancer, I'm starting to get the feeling that someone is just going through the dictionary at this point and assigning a random cause / cure value.
We've had M for milkweed today and O for Oral sex.... so next up should be Pancakesedit on 26-1-2011 by davespanners because: (no reason given)
Help to make sense of the Daily Mail's ongoing effort to classify every inanimate object into those that cause cancer and those that prevent it.